Purpose: (1) To evaluate and compare the classification performance of Wavelet-Fourier analysis (WFA), Fast-Fourier analysis (FFA), and the standard GDx-variable corneal compensator (VCC) output in identifying glaucomatous eyes from a mixed group of healthy and glaucomatous eyes with atypical retardation pattern (ARP). (2) To investigate if classification performance improves when only the superior and inferior quadrants are used for WFA and FFA. (3) To evaluate the classification performance as a function of severity of ARP.
Methods: Retinal nerve fiber layer (RNFL) estimates were obtained from 445 eyes of 240 individuals. On the basis of typical scan score (TSS), 348 eyes had typical retardation pattern (TRP) and 97 had ARP (78% TRP and 22% ARP). The classification performance of WFA and FFA classifiers was tested using three different ways: (1) Classifiers were trained on the TRP data, and tested on ARP data. (2) Classifiers were trained on TRP and 90% ARP data using 10-fold cross validation technique and tested on ARP data (10%). (3) Classifiers were trained and tested using the ARP data using 10-fold cross validation technique. Sensitivity, specificity, and Receiver Operating Characteristic Curve (ROC) areas were calculated. The classification performance was also assessed for the standard parameters of GDx-VCC.
Results: Of the standard GDx-VCC parameters, the nerve fiber indicator (NFI) had the highest ROC area (0.80). Of the shape-based analyses, WFA and FFA of the complete temporal, superior, nasal, inferior, and temporal curve had the highest ROC area (0.85 and 0.82, respectively). The difference in the ROC areas did not reach the statistically significant level (p = 0.07). On eyes with severe ARP (TSS < 60) all metrics performed similarly, but in case of moderate ARP (TSS 60 to 79), the ROC area of WFA and FFA were both greater than that of NFI (the difference was 9% and 7%, respectively).
Conclusion: Although the WFA and FFA classification performance was greater than NFI as assessed by ROC area the difference was not statistically significant.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/OPX.0b013e3181783aa2 | DOI Listing |
Neurology
February 2025
Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany.
Background And Objectives: The Chordate System administers kinetic oscillation stimulation (K.O.S) into the nasal cavity thereby potentially modulating the activity of trigemino-autonomic reflex.
View Article and Find Full Text PDFNeural Comput
January 2025
Department of Advanced Data Science, Institute of Statistical Mathematics, Tachikawa, Tokyo 190-8562, Japan
Standard domain adaptation methods do not work well when a large gap exists between the source and target domains. Gradual domain adaptation is one of the approaches used to address the problem. It involves leveraging the intermediate domain, which gradually shifts from the source domain to the target domain.
View Article and Find Full Text PDFNeuroradiol J
January 2025
Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Iran.
Introduction: The prevalence of neurodegenerative diseases has significantly increased, necessitating a deeper understanding of their symptoms, diagnostic processes, and prevention strategies. Frontotemporal dementia (FTD) and Alzheimer's disease (AD) are two prominent neurodegenerative conditions that present diagnostic challenges due to overlapping symptoms. To address these challenges, experts utilize a range of imaging techniques, including magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), functional MRI (fMRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT).
View Article and Find Full Text PDFAm J Dermatopathol
December 2024
Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain.
Introduction: The current WHO classification of melanocytic tumors distinguishes 9 pathogenic routes. This classification is based on the conceptual interpretation that melanocytic tumors evolve from benign counterparts, accumulating mutations, eventually developing into melanomas with metastatic and potentially lethal capacity. In this article, we present a molecular study of 2 melanocytic tumors that suggest a "leap" from pathogenic routes IV to I.
View Article and Find Full Text PDFGlobal Spine J
January 2025
Department of Spinal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Study Design: Retrospective Cohort Study.
Objectives: The current recommended treatment for Giant Cell Tumour (GCT) of the spine is en bloc excision. Denosumab is a monoclonal antibody reducing osteoclast activity that shows promising results when used as a neo - adjuvant treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!